These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22988593)

  • 1. Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation.
    Isaksen K; Morken IM; Munk PS; Larsen AI
    Eur J Prev Cardiol; 2012 Aug; 19(4):804-12. PubMed ID: 22988593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic interval training in patients with heart failure and an implantable cardioverter defibrillator: a controlled study evaluating feasibility and effect.
    Isaksen K; Munk PS; Valborgland T; Larsen AI
    Eur J Prev Cardiol; 2015 Mar; 22(3):296-303. PubMed ID: 24403295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
    Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
    Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aerobic interval training on measures of anxiety, depression and quality of life in patients with ischaemic heart failure and an implantable cardioverter defibrillator: A prospective non-randomized trial.
    Isaksen K; Munk PS; Giske R; Larsen AI
    J Rehabil Med; 2016 Mar; 48(3):300-6. PubMed ID: 26667151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.
    Habibović M; Versteeg H; Pelle AJ; Theuns DA; Jordaens L; Pedersen SS
    Europace; 2013 Mar; 15(3):355-61. PubMed ID: 22989939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy.
    Knackstedt C; Arndt M; Mischke K; Marx N; Nieman F; Kunert HJ; Schauerte P; Norra C
    Heart Vessels; 2014 May; 29(3):364-74. PubMed ID: 23732755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of implantable cardioverter defibrillator shocks during the first year.
    Dougherty CM; Hunziker J
    J Cardiovasc Nurs; 2009; 24(1):21-8; quiz 29-30. PubMed ID: 19114797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator.
    Dougherty CM; Glenny RW; Burr RL; Flo GL; Kudenchuk PJ
    Circulation; 2015 May; 131(21):1835-42. PubMed ID: 25792557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
    Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot.
    Opić P; Utens EM; Moons P; Theuns DA; van Dijk AP; Hoendermis ES; Vliegen HW; de Groot NM; Witsenburg M; Schalij M; Roos-Hesselink JW
    Clin Res Cardiol; 2012 Jul; 101(7):509-19. PubMed ID: 22314278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population.
    Berg SK; Svendsen JH; Zwisler AD; Pedersen BD; Preisler P; Siersbæk-Hansen L; Hansen MB; Nielsen RH; Pedersen PU
    BMC Cardiovasc Disord; 2011 Jun; 11():33. PubMed ID: 21682864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis.
    Pandey A; Parashar A; Moore C; Ngo C; Salahuddin U; Bhargava M; Kumbhani DJ; Piccini JP; Fonarow GC; Berry JD
    JACC Clin Electrophysiol; 2017 Feb; 3(2):117-126. PubMed ID: 29759383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study.
    Piotrowicz E; Zieliński T; Bodalski R; Rywik T; Dobraszkiewicz-Wasilewska B; Sobieszczańska-Małek M; Stepnowska M; Przybylski A; Browarek A; Szumowski Ł; Piotrowski W; Piotrowicz R
    Eur J Prev Cardiol; 2015 Nov; 22(11):1368-77. PubMed ID: 25261268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing).
    Piccini JP; Hellkamp AS; Whellan DJ; Ellis SJ; Keteyian SJ; Kraus WE; Hernandez AF; Daubert JP; Piña lL; O'Connor CM;
    JACC Heart Fail; 2013 Apr; 1(2):142-8. PubMed ID: 23936756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.